BSI BS EN ISO 10993-17 Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances
 |
| Purchase Information |
| Use this form to request purchase information on BSI online subscriptions. |
|
 |
Document BSI BS EN ISO 10993-17 is offered by IHS as part of an online subscription. This subscription contains many documents on the same topic.
You may also purchase this document alone from the IHS Standards Store.
BSI BS EN ISO 10993-17 Document Information:
Title
Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances
Biologische Beurteilung von Medizinprodukten. Nachweis zulaessiger Grenzwerte fuer herausloesbare Bestandteile
Evaluation biologique des dispositifs medicaux. Etablissement des limites admissibles des substances relargables
British Standards Institution
Publication Date:
Jan 1, 2002
Keywords:
- Medical equipment
- Biological analysis and testing
- Leaching
- Risk assessment
- Toxic materials
- Safety measures
- Hazards
About IHS
IHS (NYSE: IHS) is a leading global provider of critical technical information, decision-support tools and related services in a number of industries including aerospace and defense, automotive, construction, electronics, and energy. IHS serves customers ranging from large governments and multinational corporations to smaller companies and technical professionals in more than 100 countries. IHS been in business for more than 45 years and employ more than 2,300 people around the world.